RFG Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
RFG Advisory's JAZZ Position: Q3 2026 in Review
RFG Advisory opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 3,311 shares worth $767K. The stake represents 0.01% of the portfolio and ranks #695 among its holdings. This is a return to the name: RFG Advisory previously reported a position in JAZZ as recently as Q4 2014.
RFG Advisory first reported a position in JAZZ in Q4 2014 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- RFG Advisory held 3,311 shares of Jazz Pharmaceuticals worth $767K as of Q3 2026.
- Jazz Pharmaceuticals was a new RFG Advisory position in Q3 2026.
- Jazz Pharmaceuticals made up 0.01% of RFG Advisory's portfolio in Q3 2026, its #695 holding.
- RFG Advisory first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 2 quarters since.
- 277 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on RFG Advisory's 13F filing for Q3 2026, filed 3 Nov 2026.